,
Ferrari, Roberto http://orcid.org/0000-0003-2046-9175
Cardoso, J.
Fonseca, M. C.
Aguiar, C.
Moreira, J. I.
Fucili, A.
Rapezzi, C.
Funding for this research was provided by:
FONDAZIONE ANNA MARIA SECHI PER IL CUORE
Article History
Received: 9 May 2019
Accepted: 10 September 2019
First Online: 17 September 2019
Compliance with ethical standards
:
: RF has received honoraria for steering committee membership and consulting from Novartis and Servier; and speaker fees from Cipla, Lupin, Merck Serono, and Servier International. JC has consulted and received speaker fees, or investigational grants for Abbott, AstraZeneca Pharmaceuticals, Bial, Boehringer Ingelheim, Menarini, Merck Serono, Merck Sharp & Dohme, Novartis, Orion, Pfizer, Sanofi and Vifor M.C.F. has received fees from Novartis, Servier,Orion, Roche, Bayer and Vifor (companies that develop and market tests and/or treatments in the area of HF) for HF consulting, sitting on clinical study steering committees and giving lectures at congresses and other scientific sessions. CA has received lecture fees and honoraria for consultancy from Novartis and Servier. JIM has no conflict of interest. DM has no conflict of interest. CR has received honoraria (as a speaker and board member) from Novartis.